Full metadata record
DC poleHodnotaJazyk
dc.contributor.authorMarešová, Petra
dc.contributor.authorKlímová, Blanka
dc.contributor.authorVališ, Martin
dc.contributor.authorKuča, Kamil
dc.contributor.authorMohelská, Hana
dc.date.accessioned2016-12-14T13:06:31Z
dc.date.available2016-12-14T13:06:31Z
dc.date.issued2016
dc.identifier.citationE+M. Ekonomie a Management = Economics and Management. 2016, č. 3, s. 31-39.cs
dc.identifier.issn1212-3609 (Print)
dc.identifier.issn2336-5604 (Online)
dc.identifier.urihttp://hdl.handle.net/11025/22050
dc.format9 s.cs
dc.format.mimetypeapplication/pdf
dc.language.isoenen
dc.publisherTechnická univerzita v Libercics
dc.relation.ispartofseriesE+M. Ekonomie a Management = Economics and Management;cs
dc.rights© Technická univerzita v Libercics
dc.rightsCC BY-NC 4.0cs
dc.subjectParkinsonova nemoccs
dc.subjectpřímé nákladycs
dc.subjectléčbacs
dc.titleTreatment costs of Parkinson´s disease in Central Europeen
dc.typečlánekcs
dc.typearticleen
dc.rights.accessopenAccessen
dc.type.versionpublishedVersionen
dc.description.abstract-translatedThe aim of the study is to describe current values of direct costs of Parkinson’s disease in western and central Europe in comparison with other available data in order to illustrate the development of the treatment costs of Parkinson’s disease (PD) on the public sector. In this research study Drummond’s methodology is used for the speci fi cation of costs. The costs are divided into two categories. The fi rst category consists of the costs of creation and running of health care program and these costs are perceived as the used sources. The costs are calculated on the basis of the reviews of the studies from the European countries, but also on the basis of authors’ own survey in the University Hospital of Hradec Kralove conducted among 510 patients in the period of 2011-to the third quarter of 2015. Within this study the direct costs among 510 patients at the University Hospital of Hradec Kralove were explored in the period of 2011- to the third quarter of 2015. These costs included neurological examination, CT screening, blood collection, hospitalization, and drugs. The total direct costs of patient per year reached 2,032 EUR. The survey showed that the underpinning of patients with PD was bene fi cial from the costs point of view because the costs on the outpatient care were much lower in comparison with the inpatient care. In addition, patients released from the hospital are usually transferred to the establishments with subsequent care, for example into hospices, because family care due to its complexity is impossible.en
dc.subject.translatedParkinson´s deseaseen
dc.subject.translateddirect costsen
dc.subject.translatedtreatmenten
dc.identifier.doi10.15240/tul/001/2016-3-003
dc.identifier.doidx.doi.org/10.15240/tul/001/2016-3-003
dc.type.statusPeer-revieweden
Vyskytuje se v kolekcích:Číslo 3 (2016)
Číslo 3 (2016)

Soubory připojené k záznamu:
Soubor Popis VelikostFormát 
Maresova.pdfPlný text1,09 MBAdobe PDFZobrazit/otevřít
Zobrazit minimální záznam Zobrazit statistiky


Použijte tento identifikátor k citaci nebo jako odkaz na tento záznam: http://hdl.handle.net/11025/22050

Všechny záznamy v DSpace jsou chráněny autorskými právy, všechna práva vyhrazena.

hledání
navigace
  1. DSpace at University of West Bohemia
  2. Publikace ZČU / UWB Publications
  3. Časopisy ZČU / UWB Journals
  4. Ekonomie a management
  5. 2016
  6. Číslo 3 (2016)